3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Waldenstrom Macroglobulinemia
4
Multiple Myeloma
4
Lymphoma, Mantle-Cell
4
Lymphoma, Follicular
4
Lymphoma, B-Cell, Marginal Zone
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Congenital Abnormalities
4
Sezary Syndrome
3
Myeloproliferative Disorders
3
Mycosis Fungoides
3
Lymphoma, Large-Cell, Anaplastic
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Extranodal NK-T-Cell
3
Leukemia, Myeloid, Acute
3
Burkitt Lymphoma
3
Rectal Neoplasms
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large-Cell, Immunoblastic
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Monocytic, Acute
2
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Erythroblastic, Acute
2
Leukemia
2
Immunoblastic Lymphadenopathy
2
Hodgkin Disease
2
Dendritic Cell Sarcoma, Interdigitating
2
Interventions
Whole-Body Irradiation
4
Sulindac
4
Peripheral Blood Stem Cell Transplantation
4
Methotrexate
4
fludarabine phosphate
3
Selenium
3
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
3
Cetuximab
3
Biopsy
3
Tacrolimus
2
Sirolimus
2
Radiotherapy, Intensity-Modulated
2
Polymerase Chain Reaction
2
Mycophenolic Acid
2
Melphalan
2
Gene Expression Profiling
2
Etoposide
2
Darbepoetin alfa
2
Cyclosporine
2
Cyclophosphamide
2
Cisplatin
2
Busulfan
2
Aspirin
2
Aminolevulinic Acid
2
Albumin-Bound Paclitaxel
2
vandetanib
1
ruxolitinib
1
polyphenon E
1
perillyl alcohol
1
peginterferon alfa-2b
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Precancerous Conditions
×
In Situ Hybridization, Fluorescence
×
Clear all
No trials found.